Literature DB >> 18586395

Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation.

Kenichi Matsuda1, Hirotaka Sakamoto, Hiroko Mori, Koji Hosokawa, Akeo Kawamura, Minoru Itose, Mayumi Nishi, Eric R Prossnitz, Mitsuhiro Kawata.   

Abstract

Although the expression and distribution of nuclear estrogen receptors in the hippocampus has been described, it has been proposed that the nuclear receptors may not explain all aspects of estrogen function in the hippocampus. Recently, a G protein-coupled receptor for estrogen, GPR30, was identified as a membrane-localized estrogen receptor in several cancer cell lines. In this study, we examined the expression and intracellular distribution of GPR30 in the rat hippocampal formation. We found expression of GPR30 in pyramidal cells of CA1-3 and granule cells of the dentate gyrus at both mRNA and protein levels. Specific markers for intracellular organelles and immunoelectron microscopy revealed that GPR30 was mainly localized to the Golgi apparatus and partially in the endoplasmic reticulum of the neuron but could not detect the protein at the cell surface. Expression levels were not different among male, female in proestrus and female in estrus at the adult stage, but were higher in newborn male than newborn female.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586395     DOI: 10.1016/j.neulet.2008.05.108

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  52 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Estrogen actions on neuroendocrine glia.

Authors:  Paul Micevych; Galyna Bondar; John Kuo
Journal:  Neuroendocrinology       Date:  2010-03-24       Impact factor: 4.914

3.  Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats.

Authors:  Saloua Benmansour; Opeyemi S Adeniji; Anthony A Privratsky; Alan Frazer
Journal:  Neuroendocrinology       Date:  2015-07-01       Impact factor: 4.914

4.  A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.

Authors:  Jean Chrisostome Bopassa; Mansoureh Eghbali; Ligia Toro; Enrico Stefani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

Review 5.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

6.  Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation.

Authors:  Sarah H Lindsey; Ariel S da Silva; Mauro S Silva; Mark C Chappell
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

Review 7.  Emerging roles of GPER in diabetes and atherosclerosis.

Authors:  Matthias Barton; Eric R Prossnitz
Journal:  Trends Endocrinol Metab       Date:  2015-03-09       Impact factor: 12.015

8.  Estradiol-induced estrogen receptor-alpha trafficking.

Authors:  Galyna Bondar; John Kuo; Naheed Hamid; Paul Micevych
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 9.  Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-13       Impact factor: 3.072

10.  Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus.

Authors:  Li-cai Yang; Quan-Guang Zhang; Cai-feng Zhou; Fang Yang; Yi-dong Zhang; Rui-min Wang; Darrell W Brann
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.